ABOUT 4th_EHTF
> REGISTRATION​
​> AGENDA
​> ATTENDEES
​> INVESTORS
​> PRESENTERS
> SPONSORS​
> SUPPORTERS​
​> NETWORKING​
> VENUE​
> ACCOMMODATION​

> ABOUT LAST YEAR​

For the first time since the pandemic started, we are pleased to announce that the 4th Annual European HealthTech CEO Forum (EHTF) will take place In-Person on the 28th February 2023 back at the Hilton Zurich Airport Hotel. The event will be part of the Sachs Spring Life Sciences Week, which will also incorporate the 16th Annual European Life Sciences CEO Forum.

The 4th EHTF is a unique annual gathering of industry leaders from Europe, Asia and the USA. The main programme will feature more than 5 hours of high-level speeches and panel discussions focusing on investment & partnership in MedTech and Digital Health. In addition, there will be a global company showcase of 20 presentations by established public, private, emerging and seed companies, offering innovative solutions and are seeking investment and partnering opportunities. This will include a limited number of live presentations taking place in dedicated presenting tracks, alongside virtual company showcases, which will be available on demand during the virtual week. We expect around 250+ delegates from 20 countries to join us in Zurich for the networking and business opportunities. These include Digital Health, MedTech/Device companies, banks, investors and advisors with part of the audience participating virtually.

The In-Person meetings will be taking place on the 28th of February, while virtual meetings will take place on the 8th - 10th of March. For the virtual meetings, the system will allow you to have a secure audio/video call, as well as option to present slides using a screen share function and we will have a dedicated room for in-person meetings. We expect 2000+ meetings completed during SSLSW. The conference will be held in the Central European Time Zone. The programme will consist of:

Tuesday, 28th of February

• European HealthTech Scale up Challenge Panel
• Revolutionizing Patient Care: Personalized Medicines & Diagnostics Panel
• Israel Tech Panel
• Investing in Digital Health & Therapeutics Panel
• NextGen MedTech & Devices Panel
• Investor Roundtable
• Rising MedTech/HealthTech Stars Session

In-Person Meetings - 28th of February
Virtual Meetings via Online Meeting System - 8th - 10th of March
Networking Reception - 28th of February
On-Demand Content – from 8th of March

Confirmed Keynote Speakers Include:

• Philippe Menu, SVP, Chief Medical Officer, SOPHiA GENETICS

Confirmed Chairs & Speakers Include:

• Alexandra Vallon Eberhard, Senior Director - CTO, Global Partnering, Roche Diagnostics
• Ali Tinazli, CEO, Lifespin GmbH
• Amanda Stenbaek, Associate, Inkef
• Antonio Sánchez-Cordero, Vice President, Strategy & Business Development (M&A),  Thermo Fisher Scientific
• Arne-Christian Faisst, President, 4D Lifetec AG
• Asif Shahinsha, Senior Director, PharmaVentures Ltd.
• Beat Lechmann, Early Innovation Partner MedTech EMEA, Johnson & Johnson Innovation LLC
• Beat Merz, Managing Director, New Harbor Venture Partners, LLC
• Ben Maddison, Director, Investment Banking, Stifel Nicolaus Europe Limited
• Bobby Kaura, Seed Investment, Global Ecosystem & Entrepreneurial Development, Illumina For Startups
• Brian Hashemi, Executive Chairman & CEO, Novigenix SA
• Damien Ng, Thematic Research Analyst, Bank Julius Baer & Co. Ltd.
• Danchen Zhao, Investment Director, MTIP AG
• Dave Marver, CEO, ONWARD Medical N.V.
• Diana Saraceni, Founding Partner, Panakès Partners SGR S.p.A.
• Eyal Lifschitz, Co-Founder & General Managing Partner, Peregrine Ventures
• Filip Pintelon, Investment Director, Capricorn Partners
• Henrik Emmert, Co-Founder & Managing Director, aidhere GmbH
• Iwan van Vijfeijken, CEO, Pulsify Medical
• Jean-Marie Masella, Consulting Client Partner Director, ProductLife Group
• Jonas Brambeck, Senior Investment Director, Industrifonden
• Laurent Choppe, Managing Partner, Cukierman & Co. Life Sciences
• Marianne Mertens, Partner, Apollo Health Ventures
• Martin Mueller, Senior Associate Venture Investments, Philips Ventures
• Martin Pfister, Principal, High-Tech Gründerfonds Management GmbH
• Nawal Roy, Founder & CEO, Holmusk
• Ofer Barshem, CEO, Cell-Lipo LTD
• Philippe Menu, SVP, Chief Medical Officer, SOPHiA GENETICS
• Rainer Metzger, Head of Integrated Clinical Services, Medicover AB
• Rana Lonnen, Managing Director, dRx Capital, Novartis
• Regina Hodits, Managing Partner, Wellington Partners
• Rupert Winckler, Head of EMEA Business Development, Olympus Europa SE & Co. KG
• Shir Slutzky, Minister - Counselor for Economic Affairs & Head, Israel Economic and Trade Mission to Switzerland
  
• Shy Zyman, CEO, PreciHealth SA
  
• Tahera Kan, VP, Early Innovation Partnering, Johnson & Johnson Innovation LLC
• Ulrich Muehlner, Founder & Managing Director, GrowthCube Partners LLC
• Viktor Matyas, Co-Founder & CEO, AIgnostics GmbH
• Victor Savevski, Chief Innovation Officer & AI Center Director, Humanitas Research Hospital
• Wilder Fulford, Founder & Managing Director, The Fulford Group Ltd.
• Yves Nordmann, Co-Founder & CMO, docdok.health Ltd.
• Zohar Gendler, Managing Partner & CEO, NGT Healthcare II
• More TBA…

PARTICIPATION OPTIONS:

Complimentary passes are provided for qualified institutional (buy/sell-side), private equity and venture investors. The number of passes is limited, and priority is given to regular participants, however the organiser has the discretion to reject registrations. Other participants may consider purchasing access, which includes in-person or virtual participation, with different options to showcase your company.

NETWORKING OPPORTUNITIES:

The Online Meeting System will open on the 14th of February for uploading profiles and sending meeting invites. The in-person meetings will be taking place on the 28th of February, while virtual meetings will take place on the 8th - 10th of March . For the virtual meetings, the system will allow you to have a secure audio/video call, as well as an option to present slides using a screen share function and we will have a dedicated room for in-person meetings

PRESENTING OPPORTUNITIES:

Presentations are a popular and useful way to gain additional exposure with potential investors and pharma partners, which make up over half the audience. We are pleased to announce that once again we will have 20-minute and 10-minute presentations taking place in-person at the dedicated presenting tracks. Here you will be able to showcase your company in front of investors attending the physical event. The recording will be added to your company’s profile later, which will be available on demand for registered participants until the event portal closes.

For those who are not able to present in-person, but are still interested to showcase their company, there is an option to purchase either a 20 or 10 minute presentation, which will be pre-recorded in advance and available to all registered attendees on the event’s portal. Start-up companies may also purchase a 5-minute pre-recorded showcase instead.

The Sachs Team can assist with the pre-recording of the presentation, or you can upload a video you already have. Interested viewers will be able to message or request a meeting with you using the Online Meeting System.

EXHIBITING OPPORTUNITIES:

Make connections, engage in conversation, and exchange knowledge with key decision-makers eager to learn how your company can help them meet their goals and achieve their mission. Exhibiting at Sachs Spring Life Sciences Week is an effective way to gain leads, introduce new products and services, expand sales, and build relationships.

If attending the physical event, we have a limited number (limited to 3 companies) of table-top exhibitions available at the venue, which would be located at the main foyer, next to the plenary room, where we have the highest attendee traffic.

For those who are not able to join the event or exhibit in-person, you could choose virtual exhibition package, which includes a dedicated virtual page, where we can: upload your branded company’s profile and list ways to reach you; share video or images about services you provide and have files ready for download, if you wish to share any additional information with potential clients.

If interested in learning more about exhibition options, please fill in the registration form.

SPONSORING OPPORTUNITIES:

There are a limited number of sponsorship opportunities for the forum, which includes speaking, advertising, and branding options. Sponsors typically include investment banks and funds, large pharma, technology companies and service providers, including Stock Exchanges, IR companies, CROs, international lawyers and consulting companies. Tailored packages are available upon request. You can view the latest event’s sponsors here.

To learn more about presenting, exhibition or sponsorship opportunities, please fill in registration form or contact us at SachsTeam@SachsForum.com or by phone + 44 (0)203 463 4890.

Bronze Sponsors:

---

Contributing Sponsor:

---

Supporters:

---

Participating Pharmas in 2022:

---

Financial, Advisory & Investors Attending::

abcDNA GmbH
AFK & Partners Asset Management LLC
Anchor
Apollo Health Ventures
ARTO AG
ATGN Consulting
Atlas Capital Advisors LLC
Atlas Capital Markets
Bank Julius Baer & Co. Ltd.
BIOSTART Consulting GmbH
Bootstrap Europe
BROTHERS & Partners Europe
Capricorn Partners
CD-Venture GmbH
Convergence Partners AG
Corinthian Financial Management SARL
Cukierman & Co. Life Sciences
Debiopharm Innovation Fund SA
Digital Networks Plc. S.r.l.
dRx Capital, Novartis
EQT Life Sciences
Gimv
GLSV GmbH iL, MicroCures Inc, Neurevo GmbH
GrayBella Capital LLC
GrowthCube Partners LLC
H.C. Wainwright & Co., LLC
HBM Partners AG
Helsana HealthInvest AG
High-Tech Gründerfonds Management GmbH
Hitachi Ventures GmbH
HitchinRock Advisors Limited
IAG Italian Angels for Growth
ICF Consult Switzerland
Illumina For Startups
imec.xpand
Indaco Venture Partners SGR S.p.A.
Industrifonden
Inflexion Private Equity Partners
Inkef
Inveready
Karista
Kreos Capital
LOGSCALE Venture Partners
LSV Capital Partners
Lynx Financial
Momentum Biotech LLC
MTIP AG
New Harbor Venture Partners, LLC
New Science Fund
NGT Healthcare II
Norgine Ventures Management Limited
NRW.BANK
Panakès Partners SGR S.p.A.
Paul Larue Business Dev
Peregrine Ventures
PFR Ventures
Philips Ventures
Pictet & Cie SA
PMV
Privilege Ventures SA
RBV Capital
Redalpine Venture Partners AG
Schroders Capital
Stifel Nicolaus Europe Limited
Supernova Invest
TechWald Holding S.p.A.
The Fulford Group Ltd.
TruVenturo GmbH
Turos Capital AG
TVM Capital Life Science
Valor Management S.A.
VI Partners AG
Vogel BioC
Wellington Partners
XGen Venture SGR S.p.A.
yabeo Venture Tech

​To View All - Click Here